Emerson Ecologics has obtained licenses to distribute prescription and injectable therapy products in 42 states. Emerson also confirmed that they will be submitting applications in the remaining states, with the ultimate goal to have all state licensures by the end of 2014.
In addition to obtaining licenses to sell to qualified healthcare practitioners in each state, Emerson Ecologics has made additional upgrades to its Virginia distribution center to accommodate the distribution of such products and to obtain licensing by the Virginia Board of Pharmacy.
Emerson Ecologics CEO Andy Greenawalt said that the company is excited to make the investment in its infrastructure required to distribute prescription and injectable therapies and to satisfy its practitioner requests to provide these products.
"We certainly understand the importance these products have for our practitioners and their patients," Greenawalt added.
As of today, Emerson carries the brands Heel, BHI, Nature-Throid and WP Thyroid and will be adding additional products to their portfolio over time.